PHARMA

The greatest challenges facing the pharmaceutical industry today include changing customer expectations, increased self-medication, difficulties in identifying novel medicines for incurable diseases, high payer scrutiny of pharma-economic performance, the trend for governments to favour prevention over treatment, and access to emerging markets. Partnering with MI will help turn these challenges into opportunities.

What we offer

• Development of clinical psychotherapy interventions for multiple indications
• Intervention delivery at scale via an engaging mobile platform
• Objective quantification of efficacy in real time, without the need for a wearable

Partnership Models

Rx + DTx pairing

Improve efficacy & patient experience

Accelerate market access & reimbursement

Standalone DTx

Generate compound-agnostic revenue

Access actionable patient data

Clinical endpoints

Capture objective biometrics remotely

Augment mental wellbeing assessment

Patient Testimonials

"…it was helping me get through my post cancer treatments and my cancer that has been a very very rough journey."

Ms. Jacobs, breast cancer survivor (double mastectomy)

"... this [digital therapeutic] forced me to block out the world and say okay, this moment is mine right now, and I'm going to enjoy this moment for myself."

Mr. Doer, testicular cancer survivor (chemotherapy)

"…I felt like it was an actual meditation – like they were actually there with me."

Ms. Edwards, kidney cancer survivor (immunotherapy)

Contact us to start the conversation.